# Columbia Banking System, Inc.: financial statements, quarterly

COLB · Nasdaq · CIK 887343 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/colb.md) · [Financials](/companies/colb/financials.md) · [Filings](/companies/colb/filings.md) · [Insiders](/companies/colb/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/colb/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [215](/filings/0000887343-24-000262.md) | [238 d](/filings/0000887343-24-000089.md) | [261](/filings/0000887343-24-000183.md) | [268](/filings/0000887343-24-000245.md) | [269](/filings/0000887343-24-000262.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [48.1](/filings/0000887343-24-000262.md) | [33.1 d](/filings/0000887343-26-000088.md) | [45.0](/filings/0000887343-25-000166.md) | [40.9](/filings/0000887343-25-000233.md) | [50.0](/filings/0000887343-25-000268.md) | [49.0 d](/filings/0000887343-26-000088.md) | [37.0](/filings/0000887343-26-000135.md) | [51.0](/filings/0000887343-26-000170.md) | [23.0](/filings/0000887343-25-000268.md) | [67.0 d](/filings/0000887343-26-000088.md) | [63.0](/filings/0000887343-26-000135.md) | [67.0](/filings/0000887343-26-000170.md) |
| Net income | $m | [136](/filings/0000887343-24-000262.md) | [93.5](/filings/0000887343-24-000262.md) | [124](/filings/0000887343-25-000268.md) | [121](/filings/0000887343-25-000268.md) | [146](/filings/0000887343-25-000268.md) | [143](/filings/0000887343-25-000268.md) | [87.0](/filings/0000887343-26-000170.md) | [152](/filings/0000887343-26-000170.md) | [96.0](/filings/0000887343-26-000170.md) | [215](/filings/0000887343-26-000170.md) | [192](/filings/0000887343-26-000170.md) | [208](/filings/0000887343-26-000170.md) |
| Diluted EPS | $ per share | [0.65](/filings/0000887343-24-000262.md) | not reported | [0.59](/filings/0000887343-25-000166.md) | [0.57](/filings/0000887343-25-000233.md) | [0.70](/filings/0000887343-25-000268.md) | not reported | [0.41](/filings/0000887343-26-000135.md) | [0.73](/filings/0000887343-26-000170.md) | [0.40](/filings/0000887343-25-000268.md) | not reported | [0.66](/filings/0000887343-26-000135.md) | [0.73](/filings/0000887343-26-000170.md) |
| Basic EPS | $ per share | [0.65](/filings/0000887343-24-000262.md) | not reported | [0.60](/filings/0000887343-25-000166.md) | [0.58](/filings/0000887343-25-000233.md) | [0.70](/filings/0000887343-25-000268.md) | not reported | [0.41](/filings/0000887343-26-000135.md) | [0.73](/filings/0000887343-26-000170.md) | [0.40](/filings/0000887343-25-000268.md) | not reported | [0.66](/filings/0000887343-26-000135.md) | [0.73](/filings/0000887343-26-000170.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [2.4](/filings/0000887343-23-000307.md) | [2.2](/filings/0000887343-25-000054.md) | [2.2](/filings/0000887343-24-000183.md) | [2.1](/filings/0000887343-24-000245.md) | [2.1](/filings/0000887343-24-000262.md) | [1.9](/filings/0000887343-26-000088.md) | [2.1](/filings/0000887343-25-000166.md) | [1.9](/filings/0000887343-25-000233.md) | [2.3](/filings/0000887343-25-000268.md) | [2.4](/filings/0000887343-26-000170.md) | [2.1](/filings/0000887343-26-000135.md) | [1.8](/filings/0000887343-26-000170.md) |
| Total assets | $bn | [52.0](/filings/0000887343-23-000307.md) | [52.2](/filings/0000887343-25-000054.md) | [52.2](/filings/0000887343-24-000183.md) | [52.0](/filings/0000887343-24-000245.md) | [51.9](/filings/0000887343-24-000262.md) | [51.6](/filings/0000887343-26-000088.md) | [51.5](/filings/0000887343-25-000166.md) | [51.9](/filings/0000887343-25-000233.md) | [67.5](/filings/0000887343-25-000268.md) | [66.8](/filings/0000887343-26-000170.md) | [66.0](/filings/0000887343-26-000135.md) | [65.4](/filings/0000887343-26-000170.md) |
| Total liabilities | $bn | [47.4](/filings/0000887343-23-000307.md) | [47.2](/filings/0000887343-25-000054.md) | [47.3](/filings/0000887343-24-000183.md) | [47.1](/filings/0000887343-24-000245.md) | [46.6](/filings/0000887343-24-000262.md) | [46.5](/filings/0000887343-26-000088.md) | [46.3](/filings/0000887343-25-000166.md) | [46.6](/filings/0000887343-25-000233.md) | [59.7](/filings/0000887343-25-000268.md) | [59.0](/filings/0000887343-26-000170.md) | [58.4](/filings/0000887343-26-000135.md) | [57.8](/filings/0000887343-26-000170.md) |
| Long-term debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $bn | [0.0](/filings/0000887343-23-000307.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [4.6](/filings/0000887343-23-000307.md) | [5.0](/filings/0000887343-25-000054.md) | [5.0](/filings/0000887343-24-000183.md) | [5.0](/filings/0000887343-24-000245.md) | [5.3](/filings/0000887343-24-000262.md) | [5.1](/filings/0000887343-26-000088.md) | [5.2](/filings/0000887343-25-000166.md) | [5.3](/filings/0000887343-25-000233.md) | [7.8](/filings/0000887343-25-000268.md) | [7.8](/filings/0000887343-26-000170.md) | [7.7](/filings/0000887343-26-000135.md) | [7.6](/filings/0000887343-26-000170.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [350 d](/filings/0000887343-24-000262.md) | [92.5 d](/filings/0000887343-26-000088.md) | [186](/filings/0000887343-25-000166.md) | [150 d](/filings/0000887343-25-000233.md) | [67.2 d](/filings/0000887343-25-000268.md) | [256 d](/filings/0000887343-26-000088.md) | [122](/filings/0000887343-26-000135.md) | [107 d](/filings/0000887343-26-000170.md) | [236 d](/filings/0000887343-25-000268.md) | [281 d](/filings/0000887343-26-000088.md) | [494](/filings/0000887343-26-000135.md) | [295 d](/filings/0000887343-26-000170.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Dividends paid | $m | [74.9 d](/filings/0000887343-24-000262.md) | [74.6 d](/filings/0000887343-26-000088.md) | [75.0](/filings/0000887343-25-000166.md) | [75.1 d](/filings/0000887343-25-000233.md) | [74.9 d](/filings/0000887343-25-000268.md) | [75.0 d](/filings/0000887343-26-000088.md) | [75.0](/filings/0000887343-26-000135.md) | [75.0 d](/filings/0000887343-26-000170.md) | [76.0 d](/filings/0000887343-25-000268.md) | [109 d](/filings/0000887343-26-000088.md) | [107](/filings/0000887343-26-000135.md) | [105 d](/filings/0000887343-26-000170.md) |
| Share repurchases | $m | [0.1 d](/filings/0000887343-24-000262.md) | [(0.1) d](/filings/0000887343-26-000088.md) | [4.8](/filings/0000887343-25-000166.md) | [0.8 d](/filings/0000887343-25-000233.md) | [0.4 d](/filings/0000887343-25-000268.md) | [0.0 d](/filings/0000887343-26-000088.md) | [7.0](/filings/0000887343-26-000135.md) | [2.0 d](/filings/0000887343-26-000170.md) | [0.0 d](/filings/0000887343-25-000268.md) | [100 d](/filings/0000887343-26-000088.md) | [215](/filings/0000887343-26-000135.md) | [203 d](/filings/0000887343-26-000170.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [130](/filings/0000887343-23-000307.md) | [156](/filings/0000887343-24-000183.md) | [209](/filings/0000887343-24-000245.md) | [209](/filings/0000887343-24-000262.md) | [209](/filings/0000887343-25-000166.md) | [209](/filings/0000887343-25-000233.md) | [209](/filings/0000887343-25-000268.md) | [210](/filings/0000887343-26-000135.md) | [210](/filings/0000887343-26-000170.md) | [239](/filings/0000887343-25-000268.md) | [292](/filings/0000887343-26-000135.md) | [286](/filings/0000887343-26-000170.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 282,902,268 at 2026-07-31, from the cover of the [10-Q filed 2026-08-04](/filings/0000887343-26-000170.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:27 ET. No prices; not investment advice.